Neurobehavioral Differences Between Mice Receiving Distinct Neuregulin Variants as Neonates; Impact on Sensitivity to MK-801
Authors:
Open Access
- 4 May 2015
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 15 (3) , 222-236
Abstract
Neuregulin-1 (NRG1) is a well-recognized risk gene for schizophrenia and is often implicated in the neurodevelopmental hypothesis of this illness. Alternative splicing and proteolytic processing of the NRG1 gene produce more than 30 structural variants; however, the neuropathological roles of individual variants remain to be characterized. On the basis of the neurodevelopmental hypothesis of schizophrenia, we administered eNRG1 (0.1~1.0 μg/g), a core epidermal growth factor-like (EGF) domain common for all splicing NRG1 variants, to neonatal mice and compared their behavioral performance with mice challenged with a full mature form of type 1 NRG1 variant. During the neonatal stage, recombinant eNRG1 protein administrated from the periphery passed the blood-brain barrier and activated its receptor (ErbB4) in the brain. In adults, the mice receiving the highest dose exhibited lower locomotor activity and deficits in prepulse inhibition and tonedependent fear learning, although the hearing reduction of the eNRG1-treated mice may explain these behavioral deficits. Neonatal eNRG1 treatment also significantly potentiated MK-801-driven locomotor activity in an eNRG1 dose-dependent manner. In parallel eNRG1 treatment enhanced MK-801-driven c-Fos induction and decreased immunoreactivity for NMDA receptor subunits in adult brain. In contrast, mice that had been treated with the same molar dose of a full mature form of type 1 NRG1 as neonates did not exhibit hypersensitivity to MK-801. However, both animal models exhibited similar hypersensitivity to methamphetamine. Collectively, our findings suggest that aberrant peripheral NRG1 signals during neurodevelopment alter later behavioral traits and auditory functions in the NRG1 subtype-dependent manner.Keywords
This publication has 56 references indexed in Scilit:
- Developmental neuroinflammation and schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2013
- The Importance of the NRG-1/ErbB4 Pathway for Synaptic Plasticity and Behaviors Associated with Psychiatric DisordersJournal of Neuroscience, 2012
- Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?Behavioural Brain Research, 2011
- Phenotypic characterization of spatial cognition and social behavior in mice with ‘knockout’ of the schizophrenia risk gene neuregulin 1Neuroscience, 2007
- Meta-analysis shows strong positive association of the neuregulin 1 ( NRG1 ) gene with schizophreniaHuman Molecular Genetics, 2006
- Dopamine is not Required for the Hyperlocomotor Response to NMDA Receptor AntagonistsNeuropsychopharmacology, 2005
- Specific Structural Features of Heparan Sulfate Proteoglycans Potentiate Neuregulin-1 SignalingJournal of Biological Chemistry, 2005
- Selection, evolution of behavior and animal models in behavioral neuroscienceNeuroscience & Biobehavioral Reviews, 1999
- Multiple Limbic Regions Mediate the Disruption of Prepulse Inhibition Produced in Rats by the Noncompetitive NMDA Antagonist DizocilpineThe Journal of Neuroscience, 1998
- A two focal plane method for digital quantification of nuclear immunoreactivity in large brain areas using NIH-image softwareBrain Research Protocols, 1998